University of Virginia, Charlottesville, Virginia.
George Washington University, Washington, DC.
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1900-1909. doi: 10.2215/CJN.12781216. Epub 2017 Jul 14.
Telehealth and remote monitoring of a patient's health status has become more commonplace in the last decade and has been applied to conditions such as heart failure, diabetes mellitus, hypertension, and chronic obstructive pulmonary disease. Conversely, uptake of these technologies to help engender and support home RRTs has lagged. Although studies have looked at the role of telehealth in RRT, they are small and single-centered, and both outcome and cost-effectiveness data are needed to inform future decision making. Furthermore, alignment of payer and government (federal and state) regulations with telehealth procedures is needed along with a better understanding of the viewpoints of the various stakeholders in this process (patients, caregivers, clinicians, payers, dialysis organizations, and government regulators). Despite these barriers, telehealth has great potential to increase the acceptance of home dialysis, and improve outcomes and patient satisfaction while potentially decreasing costs. The Kidney Health Initiative convened a multidisciplinary workgroup to examine the current state of telehealth use in home RRTs as well as outline potential benefits and drawbacks, impediments to implementation, and key unanswered questions.
在过去十年中,远程医疗和患者健康状况的远程监测已经变得更加普遍,并且已经应用于心力衰竭、糖尿病、高血压和慢性阻塞性肺疾病等疾病。相反,这些技术在帮助开展和支持家庭肾脏替代治疗方面的应用却滞后了。虽然有研究探讨了远程医疗在肾脏替代治疗中的作用,但这些研究规模较小且为单中心研究,需要更多的结果和成本效益数据来为未来的决策提供信息。此外,需要使支付方和政府(联邦和州)的法规与远程医疗程序保持一致,同时还需要更好地了解这一过程中各利益相关方(患者、护理人员、临床医生、支付方、透析机构和政府监管机构)的观点。尽管存在这些障碍,但远程医疗具有很大的潜力,可以提高家庭透析的接受度,改善结果和患者满意度,同时可能降低成本。肾脏健康倡议召集了一个多学科工作组,研究家庭肾脏替代治疗中远程医疗的使用现状,并概述潜在的益处和缺点、实施障碍以及关键的未解决问题。